AzTrials
AzTrials

FrailtyPRACTICNCT05651659

Preventing and Approaching Crises for Frail Community-dwelling Patients Through Through Innovative Care (PRACTIC)

A study testing TIME model in the prevention and treatment of crises in frail community-dwelling people in people with Frailty, run by Sykehuset Innlandet HF at 1 site in Norway.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Preventing and approaching crises for frail community-dwelling patients through innovative care (PRACTIC). Participatory action research in a cluster randomised controlled trial. Read more about this study

Who is it for?
Any age
Conditions the study is for
Frailty
What is being tested?
TIME model in the prevention and treatment of crises in frail community-dwelling people
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteNorway
Study dates
7 Jan 2023to 31 May 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • in need of home care services
  • a score ≥5 on the Clinical Frailty Scale (indicating mild to severe frailty)
  • perceived by the home care service as being in an unstable situation with a high risk for acute institutionalisation or showing resistance to care.
  • being next of kin of a user of home care services who meets the above mentioned inclusion criteria
  • regular contact with the patient (i.e., at least once a week).

Who cannot join

  • expected short life expectancy (i.e., <4 weeks).

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Sykehuset Innlandet

    Ottestad, Norway

Other trials in Norway

About this study

Official title: Preventing and Approaching Crises for Frail Community-dwelling Patients Through Innovative Care (PRACTIC) - an Effectiveness Study

Preventing and approaching crises for frail community-dwelling patients through innovative care (PRACTIC). Participatory action research in a cluster randomised controlled trial. The primary purpose of this study is to test the effectiveness of an adapted version of a bio-psychosocial person centred model (TIME) to prevent and resolve crises for frail community-dwelling people receiving home care services. The investigators have formulated the following research questions (RQ):

RQ1: Can the TIME model adapted for home care service, prevent, and resolve crises in frail people receiving home care services? RQ2: Which participant characteristics or organizational factors are associated with the effect of the TIME model? RQ3: What are the experiences of the users of home care services on how crises were approached during the trial?

Read the detailed description

This study is part of the larger PRACTIC (Preventing and approaching crises for frail community-dwelling patients through innovative care) study. This is a six-month cluster randomized controlled trial (RCT). The trial will be conducted in 30 municipalities including 150 frail community-dwelling participants receiving homecare services judged by the services to have imminent crises. The proposed sample of 150 participants is based on a power calculation with clusters of approximately 5 participants from each of the 30 municipalities. Each municipality will be defined as a cluster and will be randomized to receive either the locally adapted TIME intervention (the intervention group) or care as usual (the control group). TIME is a manual-based, multicomponent programme that will include a rigorous assessment of the crises, one or more interdisciplinary case conferences and the testing and evaluation of customised treatment measures. For the interviews in RQ3, the investigators will use a purposeful sample of approximately 15 dyads with 15 patients and next of kin from the intervention municipalities in the RCT

Specially trained nurses (data assessors) from the project's research centre who are not affiliated with the municipalities will, together with staff members in the home care services, assess patients' baseline characteristics before randomisation. The data assessors will assess the effect of the intervention via telephone by interviewing the participants, the next of kin and the staff members who know the patient best, at three months and six months after baseline assessments. The interviews will based on a semi-structured interview guide where the participants will be asked to reflect on two main themes.

To evaluate the effects of a bio-psychosocial intervention like TIME to prevent and resolve crises in a heterogenous population, there is a need for a goal-oriented outcome compromising this variability. The goal of the intervention and the outcome will necessarily vary from patient to patient. The investigators will therefore use a individual goal-oriented interview, the PRACTIC goal-setting interview (PGI), based on The Bangor Goalsetting Interview, BGSI.

Conditions
Frailty
Being tested
TIME model in the prevention and treatment of crises in frail community-dwelling people
Keywords
frailty, crises, home care services, community-dwelling people, behavioural and psychological symptoms of dementia (BPSD), psychosocial interventions, case conferences
Medical subject headings
Frailty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TIME model in the prevention and treatment of crises in frail community-dwelling peopleOther

    TIME is a manual-based, multicomponent programme that will include a rigorous assessment of the crises, one or more interdisciplinary case conferences and the testing and evaluation of customised treatment measures.This multicomponent interdisciplinary model consisting of three overlapping phases. First the assessment phase where the care staff and the physician collaborate in a comprehensive bio-psychosocial assessment. The second phase is the reflection phase with interdisciplinary case conferences based on principles from cognitive behavioural therapy and abc-method, where a customized treatment plan is developed. The abc-method from cognitive behavioural therapy is used as an analytic tool for the analyses of the complex challenges in the case conferences. In the third phase the treatment plan is implemented and evaluated systematically.

Study groups in NCT05651659
Study groupRoleWhat they receive
Interventions municipalitiesExperimentalLocally adapted TIME (Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropsychiatric Symptoms) intervention. Municipalities will be randomly assigned to either the intervention group or the control group. A biostatician will perform the randomisation procedure independently of the project management team and the municipalities. The project management team will provide the home care services in the municipalities with the randomisation and allocation results immediately following this procedure. The intervention will start with the educational sessions (described below) within one to two weeks after randomisation.
Receives: Other: TIME model in the prevention and treatment of crises in frail community-dwelling people
Control municipalitiesNo interventionCare as usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in PGI (PRACTIC Goal-setting Interview) from baseline to 3 months

    The primary outcome of the trial is the difference in the change between intervention and control group in individual goal achievement to resolve or reduce the challenges of the crises.

    Measured: Change from baseline at 3 months using the PGI (scale of 1-10)

Secondary outcomes (17)
  1. Change in PGI (PRACTIC Goal-setting Interview)

    the differences in the change between intervention and control group in the BGSI scale at 6 months, in neuropsychiatric symptoms

    Measured: at 6 moths

  2. Change in symptoms (NPS)

    Neuropsychiatric symptoms (NPS) measured by the Neuropsychiatric Inventory (NPI-NH). Score for each symptom: 0-12 points. Total score 144.

    Measured: at 3 months

  3. Change in symptoms (NPS)

    Neuropsychiatric symptoms (NPS) measured by the Neuropsychiatric Inventory (NPI-NH). Score for each symptom: 0-12 points. Total score 144

    Measured: at 6 months

  4. Change in quality of life measured

    Quality of life measured by the Quality of Life in Late Stage Dementia scale (QUALID). The score will remain between 11 and 55, with 11 representing the highest quality of life.

    Measured: at 3 months

  5. Change in quality of life measured

    Quality of life measured by the Quality of Life in Late Stage Dementia scale (QUALID).The score will remain between 11 and 55, with 11 representing the highest quality of life.

    Measured: at 6 moths

  6. Change in distress perceived by the next of kin

    Distress perceived by the next of kin measured by the Relative Stress Scale (RSS). Total score between 0-60, higher score in an area, more likely higher relative stress.

    Measured: at 3 months

  7. Change in distress perceived by the next of kin

    Distress perceived by the next of kin measured by the Relative Stress Scale (RSS). Total score between 0-60, higher score in an area, more likely higher relative stress.

    Measured: at 6 months

  8. Change in rejection of care

    Rejection of care - Minimal Data Set (MDS)

    Measured: at 3 months

  9. Change in rejection of care

    Rejection of care - Minimal Data Set (MDS)

    Measured: at 6 months

  10. Change at Activities of Daily Living

    Activities of Daily Living - assessed with the Physical Self-Maintenance Scale (PSMS). Total score between 0-30, higher score in an area, more likely that the patient may be in need of help in that area.

    Measured: at 3 months

  11. Change at Activities of Daily Living

    Activities of Daily Living - assessed with the Physical Self-Maintenance Scale (PSMS).

    Total score between 0-30, higher score in an area, more likely that the patient may be in need of help in that area.

    Measured: at 6 months

  12. Change in medication from medical records

    Medication from medical records

    Measured: at 3 months

  13. Change in medication from medical records

    Medication from medical records

    Measured: at 6 months

  14. Institutionalization

    Change in level of care

    Measured: at 3 months

  15. Institutionalization

    Change in level of care

    Measured: at 6 months

  16. Clinical Frailty scale

    Frailty tool that evaluates specific domains including comorbidity, function, and cognition to generate a frailty score ranging from 1 (very fit) to 9 (terminally ill).

    Measured: 6 months

  17. EQ-5D questionnaire

    The EQ-5D questionnaire to evaluate pain and discomfort. The dimension pain/discomfort has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The respondent is asked to indicate his/her health state by ticking (or placing a cross) in the box against the most appropriate statement.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Dec 2022
  2. Study start7 Jan 2023
  3. Primary completion31 May 2026 (estimated)
  4. Study completion31 May 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Cluster randomized controlled trial (RCT) with two parallel groups: intervention municipalities and control municipalities
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05651659
Sponsor's protocol ID
150667
Acronym
PRACTIC
Status last verified
Apr 2026
First submitted
7 Dec 2022
Last updated
4 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Collaborating partners in the study will not have access to the individual participant data. The data collected in the study are not publicly available. De-identified participant data will be made available upon reasonable request to the members of the research team at the Research Centre for Age-related Functional Decline and Disease (AFS), Innlandet Hospital Trust.

Publications

  • Vaeringstad A, Kirkevold O, Dalbak ETG, Myhre J, Feiring IH, Bergh S, Lichtwarck B. Development of the PRACTIC Goal Setting Interview (PGSI) for Frail Community-Dwelling Patients. Feasibility, Interrater Reliability and Content validity-a Mixed Methods Study. Patient Prefer Adherence. 2025 Dec 12;19:4033-4050. doi: 10.2147/PPA.S557233. eCollection 2025.

    PubMed 41424838
  • Dalbak ETG, Vaeringstad A, Lichtwarck B, Myhre J, Holle D, Bergh S, Kirkevold O. Preventing and approaching crises for frail community-dwelling patients through innovative care (PRACTIC): study protocol for a process evaluation of a complex intervention in home care service. Trials. 2025 May 28;26(1):178. doi: 10.1186/s13063-025-08876-w.

    PubMed 40437640
  • Vaeringstad A, Dalbak ETG, Holle D, Myhre J, Kirkevold O, Bergh S, Lichtwarck B. PReventing and Approaching Crises for frail community-dwelling patients Through Innovative Care (PRACTIC): protocol for an effectiveness cluster randomised controlled trial. Trials. 2024 May 6;25(1):304. doi: 10.1186/s13063-024-08117-6.

    PubMed 38711048

Questions about this trial

What is this clinical trial studying?

A study testing TIME model in the prevention and treatment of crises in frail community-dwelling people in people with Frailty, run by Sykehuset Innlandet HF at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 4 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in PGI (PRACTIC Goal-setting Interview) from baseline to 3 months (time frame: Change from baseline at 3 months using the PGI (scale of 1-10)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05651659, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in